As no association could be found with the MEN1 mutation, we posited that the ER abnormality may be induced by the long-term impact on the endocrine disorders in this patient caused by MEN1, as pituitary prolactinoma and parathyroid adenoma were two of the major clinical phenotypes. The gene discussed is MEN1; the disease is parathyroid gland adenoma.